Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BDKRB2 | P30411 | 14/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6580648 | 0.90 | BDKRB2 (0.50) | BDKRB2 | |
| SCHEMBL5663232 | 0.88 | BDKRB2 (0.67) | BDKRB2 | |
| SCHEMBL17475440 | 0.86 | BDKRB2 (0.50) | BDKRB2 | |
| SCHEMBL17475443 | 0.86 | BDKRB2 (0.61) | BDKRB2 | |
| SCHEMBL6581342 | 0.86 | BDKRB2 (0.56) | BDKRB2 | |
| SCHEMBL17475441 | 0.85 | BDKRB2 (0.57) | BDKRB2 | |
| SCHEMBL17475445 | 0.84 | BDKRB2 (0.51) | BDKRB2 | |
| SCHEMBL17475447 | 0.82 | BDKRB2 (0.59) | BDKRB2 | |
| SCHEMBL8361810 | 0.82 | BDKRB2 (0.66) | BDKRB2 | |
| SCHEMBL6580497 | 0.81 | BDKRB2 (0.57) | BDKRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0867432-B1 | Fused N-heterocyclic compounds substituted with benzyloxy, process for their preparation and their use as bradykinin receptor antagonists | AVENTIS PHARMA GMBH (DE) | 2004-06-09 | — | — | EP | disclosed |
| US-6211196-B1 | 8-BENZYLOXY-(TETRAHYDRO)QUINOLINE DERIVATIVES; LIVER CIRRHOSIS, ALZHEIMER*S DISEASE | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2001-04-03 | — | — | US | disclosed |
| EP-0867432-A2 | Fused N-heterocyclic compounds substituted with benzyloxy, process for their preparation and their use as bradykinin receptor antagonists | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-09-30 | — | — | EP | disclosed |